Content Navigation
( All
None )
| Target and Pathway |
Top |
| Target(s) |
Lysine-specific histone demethylase 1 (LSD) |
Target Info
|
Inhibitor |
[2] |
| References |
Top |
| REF 1 |
ClinicalTrials.gov (NCT02875223) A Safety and Efficacy Study of CC-90011 in Subjects With Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's Lymphomas. U.S. National Institutes of Health.
|
| REF 2 |
Discovery of CC-90011: A Potent and Selective Reversible Inhibitor of Lysine Specific Demethylase 1 (LSD1). J Med Chem. 2020 Dec 10;63(23):14522-14529.
|
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.
